TOI
Oncology Institute Inc
NASDAQ: TOI · HEALTHCARE · MEDICAL CARE FACILITIES
$4.02
+2.74% today
Updated 2026-06-05
Market cap
$523.91M
P/E ratio
—
P/S ratio
0.96x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
Oncology Institute Inc (TOI) Insider transactions
Net insider activity
Net selling (4,228,091 shares)
Buy transactions
61
Sell transactions
39
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | CHERNETT, JOREY | 10% Owner | Buy | 12,000 | $4.75 | $57000.00 |
| 2026-05-21 | VIRNICH, DANIEL | Chief Executive Officer | Sale | 23,058 | $4.47 | $103069.26 |
| 2026-05-21 | PODNOS, YALE | Chief Medical Officer | Sale | 1,805 | $4.47 | $8068.35 |
| 2026-05-21 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 1,604 | $4.47 | $7169.88 |
| 2026-05-20 | CHERNETT, JOREY | 10% Owner | Buy | 33,500 | $4.07 | $136345.00 |
| 2026-05-19 | CHERNETT, JOREY | 10% Owner | Buy | 30,000 | $4.09 | $122700.00 |
| 2026-05-19 | CHERNETT, JOREY | 10% Owner | Buy | 5,000 | $4.05 | $20250.00 |
| 2026-04-16 | KAUSHAL, MOHIT | Director | Sale | 38,433 | $3.50 | $134534.72 |
| 2026-04-14 | KAUSHAL, MOHIT | Director | Sale | 57,286 | $3.50 | $200598.39 |
| 2026-04-09 | CHERNETT, JOREY | 10% Owner | Buy | 20,000 | $3.10 | $62000.00 |
| 2026-03-27 | VIRNICH, DANIEL | Chief Executive Officer | Sale | 670,608 | — | — |
| 2026-03-27 | VIRNICH, DANIEL | Chief Executive Officer | Sale | 98,534 | $3.07 | $302499.38 |
| 2026-03-27 | PODNOS, YALE | Chief Medical Officer | Buy | 66,446 | — | — |
| 2026-03-27 | PODNOS, YALE | Chief Medical Officer | Sale | 16,173 | $3.07 | $49651.11 |
| 2026-03-27 | LANGSAM, JEFFREY | Chief Clinical Officer | Buy | 70,270 | — | — |
| 2026-03-27 | ENGLAND, KRISTIN | Chief Administrative Officer | Buy | 55,743 | — | — |
| 2026-03-27 | CHERNETT, JOREY | 10% Owner | Buy | 27,429 | $2.96 | $81189.84 |
| 2026-03-27 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 202,914 | — | — |
| 2026-03-27 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 20,320 | $3.07 | $62382.40 |
| 2026-03-26 | CHERNETT, JOREY | 10% Owner | Buy | 50,000 | $3.15 | $157500.00 |
| 2026-03-24 | CHERNETT, JOREY | 10% Owner | Buy | 125,000 | $3.11 | $388750.00 |
| 2026-03-20 | CHERNETT, JOREY | 10% Owner | Buy | 25,000 | $3.35 | $83750.00 |
| 2026-03-17 | VIRNICH, DANIEL | Chief Executive Officer | Sale | 11,834 | $3.59 | $42484.06 |
| 2026-03-17 | PODNOS, YALE | Chief Medical Officer | Sale | 3,420 | $3.59 | $12277.80 |
| 2026-03-17 | CHERNETT, JOREY | 10% Owner | Buy | 75,000 | $3.42 | $256500.00 |
| 2026-03-17 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 1,314 | $3.59 | $4717.26 |
| 2026-03-16 | CHERNETT, JOREY | 10% Owner | Buy | 60,985 | $3.29 | $200640.65 |
| 2026-03-13 | CHERNETT, JOREY | 10% Owner | Buy | 263,000 | $2.92 | $767960.00 |
| 2026-01-02 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 247 | $3.56 | $879.32 |
| 2026-01-02 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 244 | $3.67 | $895.48 |
| 2025-12-15 | HIVELY, BRAD | Director | Sale | 13,333 | $3.77 | $50290.74 |
| 2025-11-20 | PACALA, MARK L | Director | Buy | 46,296 | — | — |
| 2025-11-20 | PACALA, MARK L | Director | Buy | 35,494 | — | — |
| 2025-11-20 | MCGEORGE, ANNE | Director | Buy | 67,901 | — | — |
| 2025-11-20 | MCGEORGE, ANNE | Director | Buy | 40,123 | — | — |
| 2025-11-20 | LING, GABRIEL | Director | Buy | 46,296 | — | — |
| 2025-11-20 | LING, GABRIEL | Director | Buy | 37,037 | — | — |
| 2025-11-20 | KAUSHAL, MOHIT | Director | Buy | 50,926 | — | — |
| 2025-11-20 | KAUSHAL, MOHIT | Director | Buy | 40,123 | — | — |
| 2025-11-20 | JOHNSON, KAREN MARIE | Director | Buy | 47,840 | — | — |
| 2025-11-20 | JOHNSON, KAREN MARIE | Director | Buy | 37,037 | — | — |
| 2025-11-20 | HIVELY, BRAD | Director | Buy | 41,667 | — | — |
| 2025-11-20 | HIVELY, BRAD | Director | Buy | 32,407 | — | — |
| 2025-11-18 | PACALA, MARK L | Director | Sale | 46,630 | $4.00 | $186520.00 |
| 2025-11-18 | PACALA, MARK L | Director | Sale | 2,160 | $4.00 | $8640.00 |
| 2025-11-18 | PACALA, MARK L | Director | Sale | 1,210 | $4.00 | $4840.00 |
| 2025-11-18 | M33, GROWTH I L.P. | Director | Sale | 2,500,000 | — | — |
| 2025-11-18 | M33, GROWTH I L.P. | Director | Sale | 590,892 | — | — |
| 2025-11-18 | M33, GROWTH I L.P. | Director | Buy | 11,818 | — | — |
| 2025-11-18 | LING, GABRIEL | Director | Buy | 141,149 | — | — |
| 2025-11-17 | VIRNICH, DANIEL | Chief Executive Officer | Buy | 6,464 | — | — |
| 2025-11-17 | PODNOS, YALE | Chief Medical Officer | Buy | 2,086 | — | — |
| 2025-11-17 | CARTER, ROBERT ROSS | Chief Financial Officer | Buy | 195 | — | — |
| 2025-11-12 | VIRNICH, DANIEL | Chief Executive Officer | Buy | 6,211 | — | — |
| 2025-11-12 | PODNOS, YALE | Chief Medical Officer | Buy | 1,202 | — | — |
| 2025-11-12 | PODNOS, YALE | Chief Medical Officer | Buy | 306 | — | — |
| 2025-09-04 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 6,018,168 | $3.09 | $18.60M |
| 2025-09-04 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 681,832 | $3.09 | $2.11M |
| 2025-08-19 | HIVELY, BRAD | Director | Sale | 20,221 | $4.06 | $82097.26 |
| 2025-07-24 | BARASCH, RICHARD A | Director | Sale | 287,756 | — | — |
| 2025-07-22 | ENGLAND, KRISTIN | Chief Administrative Officer | Buy | 98,037 | — | — |
| 2025-06-18 | BARASCH, RICHARD A | Director | Buy | 620,400 | — | — |
| 2025-06-18 | BARASCH, RICHARD A | Director | Sale | 6,204 | — | — |
| 2025-06-17 | BARASCH, RICHARD A | Director | Sale | 679,224 | — | — |
| 2025-06-17 | BARASCH, RICHARD A | Director | Buy | 679,224 | $1.20 | $813710.35 |
| 2025-06-17 | BARASCH, RICHARD A | Director | Sale | 311,128 | $2.62 | $813724.17 |
| 2025-06-17 | BARASCH, RICHARD A | Director | Buy | 159,500 | — | — |
| 2025-06-17 | BARASCH, RICHARD A | Director | Sale | 1,595 | — | — |
| 2025-06-05 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 673,676 | $3.05 | $2.05M |
| 2025-06-05 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 76,324 | $3.05 | $232788.20 |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 946,460 | — | — |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 684,528 | — | — |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 131,297 | — | — |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 105,320 | — | — |
| 2025-06-03 | HIVELY, BRAD | Director | Sale | 1,867,605 | $2.87 | $5.36M |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 946,460 | $0.85 | $804491.00 |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 684,528 | $0.85 | $581848.80 |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 131,297 | $1.87 | $245525.39 |
| 2025-06-03 | HIVELY, BRAD | Director | Sale | 108,532 | $2.87 | $311519.40 |
| 2025-06-03 | HIVELY, BRAD | Director | Buy | 105,320 | $0.48 | $50658.92 |
| 2025-05-21 | VIRNICH, DANIEL | Chief Executive Officer | Sale | 20,388 | $2.68 | $54537.90 |
| 2025-05-21 | PODNOS, YALE | Chief Medical Officer | Sale | 1,801 | $2.68 | $4817.67 |
| 2025-05-21 | LANGSAM, JEFFREY | Chief Clinical Officer | Buy | 57,380 | — | — |
| 2025-05-21 | CASTLE, JEREMY | Chief Operating Officer | Sale | 5,636 | $2.68 | $15076.30 |
| 2025-05-21 | CARTER, ROBERT ROSS | Chief Financial Officer | Sale | 1,601 | $2.68 | $4282.67 |
| 2025-05-20 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 1,796,468 | $2.71 | $4.87M |
| 2025-05-20 | M33, GROWTH I L.P. | Director, 10% Owner | Sale | 203,532 | $2.71 | $552161.96 |
| 2025-03-31 | VIRNICH, DANIEL | Chief Executive Officer | Buy | 1,083,334 | — | — |
| 2025-03-31 | PODNOS, YALE | Chief Medical Officer | Buy | 157,088 | — | — |
| 2025-03-31 | CASTLE, JEREMY | Chief Operating Officer | Buy | 162,281 | — | — |
| 2025-03-31 | CARTER, ROBERT ROSS | Chief Financial Officer | Buy | 197,368 | — | — |
| 2025-03-26 | VIRNICH, DANIEL | Chief Executive Officer | Buy | 11,320 | $0.13 | $1415.00 |
| 2025-03-26 | VIRNICH, DANIEL | Chief Executive Officer | Buy | 22,640 | $1.04 | $23584.09 |
| 2025-03-26 | PODNOS, YALE | Chief Medical Officer | Buy | 4,528 | $0.13 | $566.00 |
| 2025-03-26 | PODNOS, YALE | Chief Medical Officer | Buy | 9,056 | $1.04 | $9433.64 |
| 2025-03-26 | PACALA, MARK L | Director | Buy | 42,281 | $0.13 | $5285.13 |
| 2025-03-26 | PACALA, MARK L | Director | Buy | 90,562 | $1.04 | $94338.44 |
| 2025-03-26 | M33, GROWTH I L.P. | Director, 10% Owner | Buy | 1,358,449 | $0.13 | $169806.13 |
| 2025-03-26 | M33, GROWTH I L.P. | Director, 10% Owner | Buy | 2,716,898 | $1.04 | $2.83M |
| 2025-03-26 | JOHNSON, KAREN MARIE | Director | Buy | 18,112 | $0.13 | $2264.00 |
Frequently asked questions
Are TOI insiders buying or selling?
Over the transactions on record, TOI insiders have been net buyers, with about $36.24M in stock sold across 39 sales, against 26 open-market purchases.
Does insider selling at TOI mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which TOI insiders are selling the most?
Recent selling is concentrated in a few names. M33, GROWTH I L.P. accounts for the largest share on record, with about $28.42M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.